These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21445235)

  • 41. Epigenetic modification of Rta (ORF50) promoter is not responsible for distinct reactivation patterns of murine gammaherpesviruses.
    Lapuníková B; Lopušná K; Benkóczka T; Golais F; Kúdelová M; Režuchová I
    Acta Virol; 2015 Dec; 59(4):405-12. PubMed ID: 26666189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency.
    Clambey ET; Virgin HW; Speck SH
    J Virol; 2000 Feb; 74(4):1973-84. PubMed ID: 10644370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection.
    Samreen B; Tao S; Tischer K; Adler H; Drexler I
    Front Immunol; 2019; 10():2984. PubMed ID: 31921215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CCAAT/enhancer binding proteins play a role in oriLyt-dependent genome replication during MHV-68 de novo infection.
    Qi J; Gong D; Deng H
    Protein Cell; 2011 Jun; 2(6):463-9. PubMed ID: 21748596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination.
    Stewart JP; Micali N; Usherwood EJ; Bonina L; Nash AA
    Vaccine; 1999 Jan; 17(2):152-7. PubMed ID: 9987149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection.
    Dutia BM; Allen DJ; Dyson H; Nash AA
    Virology; 1999 Sep; 261(2):173-9. PubMed ID: 10497103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated chemokine responses are maintained in lungs after clearance of viral infection.
    Weinberg JB; Lutzke ML; Efstathiou S; Kunkel SL; Rochford R
    J Virol; 2002 Oct; 76(20):10518-23. PubMed ID: 12239330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The wood mouse is a natural host for Murid herpesvirus 4.
    Blasdell K; McCracken C; Morris A; Nash AA; Begon M; Bennett M; Stewart JP
    J Gen Virol; 2003 Jan; 84(Pt 1):111-113. PubMed ID: 12533706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purification of recombinant M3 proteins of murine gammaherpesviruses 68 and 72 expressed in Escherichia coli.
    Pančík P; Bauerová-Hlinková V; Kúdelová M
    Acta Virol; 2013; 57(1):59-68. PubMed ID: 23530825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis of murine gammaherpesvirus-68 infection in interleukin-6-deficient mice.
    Sarawar SR; Brooks JW; Cardin RD; Mehrpooya M; Doherty PC
    Virology; 1998 Sep; 249(2):359-66. PubMed ID: 9791027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunological control of murine gammaherpesvirus infection is independent of perforin.
    Usherwood EJ; Brooks JW; Sarawar SR; Cardin RD; Young WD; Allen DJ; Doherty PC; Nash AA
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():2025-30. PubMed ID: 9267003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Murine gammaherpesvirus 68 glycoprotein 150 does not contribute to latency amplification in vivo.
    Ruiss R; Ohno S; Steer B; Zeidler R; Adler H
    Virol J; 2012 Jun; 9():107. PubMed ID: 22681851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of murid gammaherpesvirus 4 infection in mice and in a natural host, bank voles.
    François S; Vidick S; Sarlet M; Michaux J; Koteja P; Desmecht D; Stevenson PG; Vanderplasschen A; Gillet L
    J Gen Virol; 2010 Oct; 91(Pt 10):2553-63. PubMed ID: 20538905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential requirement for CD28 and CD80/86 pathways of costimulation in the long-term control of murine gammaherpesvirus-68.
    Lyon AB; Sarawar SR
    Virology; 2006 Dec 5-20; 356(1-2):50-6. PubMed ID: 16934307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection.
    Aricò E; Robertson KA; Belardelli F; Ferrantini M; Nash AA
    Vaccine; 2004 Mar; 22(11-12):1433-40. PubMed ID: 15063566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency.
    Krug LT; Collins CM; Gargano LM; Speck SH
    J Virol; 2009 May; 83(10):4732-48. PubMed ID: 19264770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis.
    Lee BJ; Santee S; Von Gesjen S; Ware CF; Sarawar SR
    J Virol; 2000 Mar; 74(6):2786-92. PubMed ID: 10684295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gammaherpesvirus targets peritoneal B-1 B cells for long-term latency.
    Rekow MM; Darrah EJ; Mboko WP; Lange PT; Tarakanova VL
    Virology; 2016 May; 492():140-4. PubMed ID: 26945150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68.
    Sarawar SR; Cardin RD; Brooks JW; Mehrpooya M; Hamilton-Easton AM; Mo XY; Doherty PC
    J Virol; 1997 May; 71(5):3916-21. PubMed ID: 9094668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gamma interferon blocks gammaherpesvirus reactivation from latency.
    Steed AL; Barton ES; Tibbetts SA; Popkin DL; Lutzke ML; Rochford R; Virgin HW
    J Virol; 2006 Jan; 80(1):192-200. PubMed ID: 16352543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.